CLC Bio Inks Japan Distribution Deal | GenomeWeb

NEW YORK (GenomeWeb News) – CLC Bio today said that it has signed a distribution agreement for its next generation sequencing solutions in Japan.

The Aarhus, Denmark-based firm has signed Filgen as a reseller of its products in the Japanese market.

CLC Bio also named David Leangen as CEO of its CLC Bio Japan business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.